UPDATE 2-AstraZeneca's immunotherapy drug wins key lung cancer approval

* Rival BMS, Merck, Roche drugs approved for later disease (Adds shares, analyst reaction)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.